In turn, this might also suggest that activation of Wnt signalling in androgen independent prostate cancer cells could act synergistically with PP2A to promote stabilization of β-catenin and E-Cadherin leading to reduced EMT. The gene discussed is CDH1; the disease is prostate carcinoma.